Literature DB >> 32022615

Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.

Alhadi Almangush1,2,3,4, Ilmo Leivo3, Antti A Mäkitie5,2,6.   

Abstract

Background: The immune response has an important role in cancer progression. At the same time, anti-tumor effect of the immune response has been speculated to cause destruction of cancer cells. Recent studies have highlighted the significance of tumor-infiltrating lymphocytes (TILs) in different cancers. The International Immuno-Oncology Biomarkers Working Group has in 2017 published a practical review proposing a standardized method to assess TILs in the routine hematoxylin and eosin (HE) stained sections.Aims/objectives: To discuss the association between TILs and survival in head and neck squamous cell carcinoma (HNSCC).Material and methods: We review recent studies having assessed TILs in HNSCC and showing that tumors having low TILs associate significantly with worse survival.
Results: These findings underline that HNSCC cases with low TILs might benefit from multimodality treatment and might be indicated to receive immunotherapy.Conclusions: The evaluation of TILs using routine HE-stained sections is practical and can be considered in assessment of antitumor activity.Significance: Here, we highlight the impact of overall assessment of TILs using the routine HE-stained specimens in HNSCC.

Entities:  

Keywords:  Head and neck squamous cell carcinoma (HNSCC); Tumor-infiltrating lymphocytes (TILs); clinical behavior

Year:  2020        PMID: 32022615     DOI: 10.1080/00016489.2020.1720284

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

Review 1.  Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.

Authors:  Juan P Rodrigo; Mario Sánchez-Canteli; Fernando López; Gregory T Wolf; Juan C Hernández-Prera; Michelle D Williams; Stefan M Willems; Alessandro Franchi; Andrés Coca-Pelaz; Alfio Ferlito
Journal:  Biomedicines       Date:  2021-04-28

Review 2.  Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.

Authors:  Qiang Xu; Meiyu Fang; Jing Zhu; Haoru Dong; Jun Cao; Lin Yan; Fransisca Leonard; Felix Oppel; Holger Sudhoff; Andreas M Kaufmann; Andreas E Albers; Xu Qian
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580

3.  Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma.

Authors:  Borghild Ljokjel; Hilde Haave; Stein Lybak; Olav Karsten Vintermyr; Lars Helgeland; Hans Jørgen Aarstad
Journal:  Cancers (Basel)       Date:  2022-03-15       Impact factor: 6.639

4.  Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group.

Authors:  Alhadi Almangush; Lauri Jouhi; Timo Atula; Caj Haglund; Antti A Mäkitie; Jaana Hagström; Ilmo Leivo
Journal:  Br J Cancer       Date:  2022-01-18       Impact factor: 9.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.